A medical agent administration device may comprise a main body including a central region and a peripheral region. The peripheral region may have a plurality of petal members extending outwardly from the central region. The device may further comprise at least one coupling on a first face of the central region. The device may further comprise at least one sharp bearing body on an opposing face of the central region. Each of the at least one sharp bearing body may be in fluid communication with a respective one of the at least one coupling.

A dual chambered syringe includes: an inner barrel defining a first inner chamber, the inner barrel having an apertured stopper at its distal end, the inner barrel being open at its proximal end; a shaft adapted to fit within the inner barrel, the shaft having a distal end which is engageable with the aperture of the stopper; a device for controlling engaging and disengaging of the distal end of the shaft with the aperture of the stopper; an outer barrel concentric with the inner barrel defining a second inner chamber, the outer barrel having a distal end for receiving and dispensing fluids and a proximal end into which the distal end of the inner barrel is insertable into the second inner chamber; the apertured stopper engages the second inner chamber of the outer barrel and selectively prevents or permits the passage of fluids between the outer barrel second chamber and the inner barrel first chamber; the inner barrel having an engageable surface on its outside surface; and, the outer barrel having operatively associated therewith an engaging device for selective engagement and disengagement with the engageable surface on the inner barrel.

A method for manufacturing a hollow protruding implement (1) including a fine hollow protrusion (3) having an opening (3h) of the present invention includes a protrusion forming step of inserting a projecting mold part (11) into a base material sheet (2A) from one face (2D) side thereof, the base material sheet containing a thermoplastic resin, thereby forming a non-penetrated hollow protrusion (3) projecting from another face (2U) side of the base material sheet (2A). Subsequently, an opening forming step is performed in which an opening (3h) that penetrates the hollow protrusion (3) is formed by using a contactless opening forming means disposed on the other face (2U) side of the base material sheet (2A).

An apparatus for delivering an agent to a target recipient includes a planar substrate having a first surface and a second surface, a reservoir defined in the first surface of the planar substrate, and a plurality of microstructures projecting from the second surface of the planar substrate. Each of the plurality of microstructures includes a delivery channel that extends from the reservoir to a channel opening defined in an exterior surface of the microstructure. In some embodiments, a needle with microchannels can be fabricated using a silicon wafer. A primary channel is etched into the wafer, and then a second silicon wafer can be bonded on top of the initial wafer. Microchannels can be formed from the primary channel to a surface of the wafer using deep reactive ion etching. The diameter of the microchannels may be chosen for drug delivery. The illustrative diameter of the microchannels is 4 micrometers.

The microneedle assembly of the present invention includes: a main body (110) opened at one side thereof and including a solution reservoir (111) formed in the opened side thereof; a dispensing unit (120) disposed at the other side of the main body (110) in such a manner as to fluidically communicate with the solution reservoir (111); a needle supports (130) positioned at a front portion of each of the dispensing units (120), and protrudingly formed at the other end of the main body (110); a microneedles (140) engaged with the front end of the needle support (130); and a first solution release flow channel (150) formed to penetrate through a portion extending outwardly from a front end of the dispensing unit (120) to the front end of the needle support (130).

A microneedle for intradermal injection or diagnostics, constructed as a protrusion above a substrate and whose shape is defined by a pair of vertical side surfaces, configured to be symmetrical about a vertical plane of symmetry and to meet along a vertical leading edge, and by an inclined surface, intersecting the side surfaces, the microneedle also including a vertical bore, located centrally between the two side surfaces and substantially near the leading edge, wherein each of the side surfaces is divided, sequentially along the front-to-back direction, into at least two contiguous planar segments, forming pairs of corresponding segments along the respective side surfaces; each pair of corresponding segments mutually form an acute angle, the angle being between 40 and 70 degrees for the pair of segments adjacent the leading edge and less than 35 degrees for the pair of segments farthest from the leading edge
and wherein the leading edge is formed so that its profile includes an arc, joined to the side surfaces.

A microneedle assembly that is capable of delivering a drug compound (e.g., vaccine) and/or detecting the presence of an analyte is provided. The assembly comprises at least one microneedle extending outwardly from a support. The microneedle includes a polymer composition containing a thermoplastic polymer having a melting temperature of about 250° C. or more. The polymer composition exhibits a melt viscosity of about 100 Pa-s or less and a tensile elongation of about 5% or less.

A microneedle for intradermal injection or diagnostics, constructed as a protrusion above a substrate and whose shape is defined by a pair of vertical side surfaces, configured to be symmetrical about a vertical plane of symmetry and to meet along a vertical leading edge, and by an inclined surface, intersecting the side surfaces, the microneedle also including a vertical bore, located centrally between the two side surfaces and substantially near the leading edge,

wherein each of the side surfaces is divided, sequentially along the front-to-back direction, into at least two contiguous planar segments, forming pairs of corresponding segments along the respective side surfaces; each pair of corresponding segments mutually form an acute angle, the angle being between 40 and 70 degrees for the pair of segments adjacent the leading edge and less than 35 degrees for the pair of segments farthest from the leading edge
and wherein the leading edge is formed so that its profile includes an arc, joined to the side surfaces.

Disclosed are medical devices that incorporate siRNA. In addition to one or more siRNA constructs, devices include nanostructures fabricated on a surface to form a nanotopography. A random or non-random pattern of structures may be fabricated such as a complex pattern including structures of differing sizes and/or shapes. Microneedles may be incorporated on devices. The pattern including nanostructures may be formed on the surface of the microneedles.

A device and method for delivering a high viscosity composition is described. The composition includes a bioactive agent for delivery to a subject in need thereof. The method delivers the bioactive agent at a high bioavailability and with little loss of agent to the natural defense mechanisms of the body. The device includes one or more microneedles with structures fabricated on a surface of the microneedles to form a nanotopography. A random or non-random pattern of structures may be fabricated such as a complex pattern including structures of differing sizes and/or shapes.